PBAC recommends new NIP adult vaccine listings

New Pharmaceutical Benefits Advisory Committee (PBAC) recommendations could significantly change who can access funded COVID-19 and RSV vaccines. At its December 2025 meeting, PBAC considered...

High interruption rates threaten patient safety

New research has found that pharmacists are interrupted at alarming rates when dispensing medicines. Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...

What pharmacists need to know about new prescribing pilots

On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.

FAQ: clozapine’s close checks

Clozapine, used for the management of treatment-resistant schizophrenia, is subject to strict regulatory and monitoring requirements.

Intranasal naloxone spray could reduce opioid-related deaths

Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...

What a National Medicines Record might mean for patient safety and...

Australia's Minister for Health has announced a National Medicines Record. What is it, and what will it achieve?